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Abstract:
Background:
Risk factors identification associated with status epilepticus is valuable in order to prevent morbidity and mortality in children. This study aimed to
consider the etiology, risk factors, morbidity and mortality in children with status epilepticus.
Methods:
This retrospective cross-sectional study was performed on 119 patients aged from one month old to 15 years old. Patients’ data were recorded,
including basic demographic, etiology and clinical information. The different risk factors correlated to morbidity and mortality were evaluated in
this study.
Results:
The most common etiologies were acute symptomatic and febrile status epilepticus by 32.8% and 22.7%, respectively. Abnormal brain imaging
results were reported far more frequently in patients with a history of neurodevelopmental delay and previous status epilepticus (p<0.001). The
overall morbidity and mortality rates were 18.9% and 10.9%, respectively; while these rates in patients with delayed development (45.16% and
18.42%, respectively)  were  significantly  higher  than patients  with  normal  development  (8% and 7.4%, respectively).  The morbidity  rates  in
patients with previous seizures and previous status epilepticus were remarkably higher than those without previous history of seizure (26.41% vs
11.32%; p=0.047) and without previous status epilepticus (36.36% versus 14.28%; p=0.018). The length of hospital stay in patients with mortality
was considerably longer than patients without mortality (12.30 ± 16.1 days vs 7.29 ± 6.24 days; p=0.033). The mortality rate in patients with
normal Lumbar Puncture result was notably lower than those with abnormal LP result (2.9% vs 50%). The morbidity rate in patients with abnormal
brain imaging results (p<0.001) was significantly greater than those in patients with normal results. The mortality rate was relatively higher in
patients with abnormal imaging results compared to those normal results. Etiology was an important predictor of mortality and morbidity rates;
acute symptomatic (32.8%), febrile status epilepticus (22.7%) and remote symptomatic (16.8%) etiologies were the most common underlying
causes of S.E. While in children less than 3 years old, the acute symptomatic etiology and febrile status epilepticus etiologies were estimated as the
most common, in most patients older than 3 years old the most common etiology of status epilepticus was unknown. Congenital brain defects
etiology had the highest mortality (36.36%) and morbidity (42.85%) rate. The lowest morbidity (3.84%) and mortality (0%) rates were for patients
with febrile status epilepticus etiology.
Conclusion:
Age, developmental delay, history of previous status epilepticus, the length of hospital stay, abnormal brain imaging results and the underlying
etiology of status epilepticus were associated with increased morbidity and mortality among children with status epilepticus.
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1. INTRODUCTION
Status  epilepticus  (SE)  is  a  prevalent  life-threatening
condition  in  children  which  is  defined  according  to  ILAE
(International League Against Epilepsy) as prolonged (longer
than  5  minutes  in  generalized  tonic-clonic  convulsion,  more
than 10 minutes in focal seizures and greater than 20 minutes
in absence seizures) continuous seizure activity or two or more
sequential  seizures  without  normal  consciousness  between
them  [1,  2].  Early  diagnosis  and  initiation  of  treatment  are
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crucial  since  SE  can  result  in  significant  brain  damage  [3].
Generally,  the  incidence  of  SE  is  estimated  at  about  18-28
cases per 100,000 persons yearly [4, 5]. The prevalence of SE
in  the  United  States  is  50,000-150,000  per  year  [6].  The
incidence of SE is increasing in developing countries [7]. In a
recent study in Iran, the prevalence of SE was 17.3% among
children with seizures [8].
Status epilepticus can have devastating consequences like
neuronal injuries, a decline in motor and cognitive skills and
even death. This imposes considerable challenges to the health
system. Negative effects of SE depend on the duration and type
of  seizures  [5].  Generally,  SE  divides  into  two  groups:
convulsive  and  non-convulsive.  There  are  four  types  of  SE,
including generalized, focal, non-convulsive and neonatal [8].
The  most  common  form  of  SE  is  generalized  tonic  clonic
(GTC),  which  is  accompanied  by  the  highest  morbidity  and
mortality prevalence among children [9]. Most episodes of SE
happen in the absence of prior seizure history. In the general
population, infants and the elderly are the groups at higher risk
for  developing  SE.  Recent  data  reveals  that  approximately
10-20% of children with epilepsy will develop one episode of
SE [10, 11].
One  of  the  most  important  issues  regarding  the
management of seizure in children is to identify the etiology
associated  with  SE  regarding  the  prevention  of  disease  and
reduction in its  morbidity and mortality rates [12].  In adults,
some  known  etiologies  are  reported  as  fever,  cerebral
infections,  electrolyte  imbalance,  anti-convulsive  drug
withdrawal,  cerebrovascular  disease,  trauma  and  congenital
anomalies.  The  etiology  and  risk  factors  of  SE  are  less
identified  in  pediatrics  [13].  Thus,  identification  of  etiology
and the most prevalent risk factors for SE in children can help
us to decrease SE related morbidity and mortality. The purpose
of recent research is to investigate associated risk factors and
etiologies of SE and correlation with morbidity and mortality
in the Iranian pediatric age group.
2. MATERIALS AND METHODS
In this retrospective and cross-sectional study, all patients
with SE aged from one month old to 15 years old admitted to
Hazrat-e Rasool Hospital (Tehran, Iran) were enrolled in this
study between the years 2007 to 2018. Fig. (1) is illustrating
the process of patients’ selection. The study was approved by
the Ethics Committee of Iran University of Medical Sciences
(IR.IUMS.FMD.REC.1398.105). At the beginning of the study,
a  checklist  was  prepared  in  order  to  collect  information  on
demographic  and  basic  clinical  data,  including  age,  sex,
developmental status (normal or delayed), history of previous
seizure,  seizure  type  (focal  or  generalized),  duration  of  the
seizure  (over  60  minutes  and  less  than  60  minutes),  family
history of febrile convulsion (FC), family history of epilepsy,
history of previous SE, length of hospital stay, etiology (febrile
status  epilepticus,  acute  symptomatic,  remote  symptomatic,
congenital  brain  abnormalities,  unknown),  lumbar  puncture
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results  (normal  or  abnormal),  brain  imaging  (CT  scan  and
MRI), electroencephalography (EEG), and the morbidity and
mortality rates following status epilepticus. Any abnormality in
CT  scan  or  MRI,  including  congenital  or  acquired,  was
recorded as abnormal imaging results. Patients with a history of
congenital diseases despite brain abnormalities, aged older than
15  years  old  or  less  than  one-month  old  and  SE  caused  by
trauma,  were  excluded  from the  present  study.  According  to
the inclusion and exclusion criteria, 119 patients were enrolled
in this  research.  The checklists  were completed according to
medical records and information achieved by patients’ follow-
ups.  The  relationship  between  all  parameters  and  status
epilepticus,  morbidity  and  mortality  rates  was  considered  in
these patients.
3. STATISTICAL ANALYSIS
All quantitative data were analyzed using the descriptive
program  and  presented  as  Mean  ±  SD.  Crosstabs  and  Chi-
Square  tests  were  used  to  compare  parameters  between  two
groups.  The  comparison  of  the  mean  in  parametric  data
between  two  groups  was  analyzed  using  an  independent
student sample t-test. In this study, a p-value of less than 0.05
was considered statistically considerable. The SPSS software
(IBM, version 19) was applied for data analysis.
4. RESULTS
A  total  of  119  cases  with  a  mean  age  of  45.05  ±  40.37
months  were  enrolled  in  the  study.  The  results  of  the  basic
demographic and clinical findings of all cases are summarized
in Table 1. The percentage of patients less than 3 years old and
older  than  3  years  old  was  50.4% (60  cases)  and  49.6% (59
cases), respectively. Of all patients, 68 patients (57.1%) were
male  and  51  cases  (42.9%)  were  female.  There  was  no
remarkable  difference  in  the  mean  age  of  patients  between
males and females (41.47 ± 40.6 vs 49.83 ± 39.95 months-old;
p=0.26).  The  medical  history  of  all  patients  revealed  that
32.2% (38 cases) had delayed development. The prevalence of
delayed development in boys and girls was 32.35% (22 cases)
and 31.37% (16 cases), respectively (p=0.91). The prevalence
of previous seizure and SE was 50.4% and 20.2%, respectively.
Moreover, 70 patients (58.8%) had SE with fever. Compared to
focal  seizure  found  in  21.1%  of  cases,  the  generalized  form
was the most common type of seizure among patients (78.9%).
The  percentage  of  patients  with  a  family  history  of  FC  and
epilepsy was 11.8% and 21.0%. Acute symptomatic and febrile
status  epilepticus  were  the  first  and  second  most  common
etiologies  by  32.8%  and  22.7%,  respectively.  There  was  no
significant  difference  in  the  frequency  of  these  parameters
between  males  and  females.
A considerable difference was found among the etiology
between patients in two age groups (Table 2; p<0.001). While
acute  symptomatic  etiology  was  the  highest  cause  of  SE
occurrence in patients less than 3 years old (38.33%), thus the
highest prevalent etiology of SE in patients aged over 3 years
old was unknown (30.50%).  The prevalence of  febrile  status
epilepticus in children aged less than 3 years old (28.33%) was
approximately two times more than patients aged over 3 years
old (16.94%).
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Fig. (1). Study design and the process of patient’s selection.
Table 1. The basic demographic and clinical characteristics of patients.
Variables Results
Age (Month) 45.05 ± 40.37
Age groups
     >3 years (%) 59 (49.6%)
     <3 years (%) 60 (50.4%)
Gender
     Boys (%) 68 (57.1%)
     Girls (%) 51 (42.9%)
Developmental history
     Normal (%) 81 (67.8%)
     Delayed (%) 38 (32.2%)
Previous seizure
     Yes (%) 60 (50.4%)
     No (%) 59 (49.6%)
Seizure type
     Focal (%) 29 (21.1%)
     Generalized (%) 90 (78.9%)
Seizure lasting (minute) 42.58 ± 37.73
Previous status
     Yes (%) 24 (20.2%)
     No (%) 95 (79.8%)
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Variables Results
Status with fever
     Yes (%) 70 (58.8%)
     No (%) 49 (41.2%)
Family history of FC
     Yes (%) 14 (11.8%)
     No (%) 105 (88.2%)
Family history of epilepsy
     Yes (%) 25 (21.0%)
     No (%) 94 (79.0%)
Hospital stay (day) 8.0 ± 7.85
Etiology
     Status F.C 27 (22.7%)
     Acute symptomatic 39 (32.8%)
     Remote symptomatic 20 (16.8%)
     Congenital brain defects 11 (9.2%)
     Unknown 22 (18.5%)
LP
     Normal 69 (58.0%)
     Abnormal 2 (1.7%)
     No provided 48 (40.3%)
Table 2. Comparison of the frequency of disease etiology between age groups.
Age group
N p-value
Under 3 years Over 3 years
Etiology
Status F.C 17 (28.33%) 10 (16.94%) 27
<0.001
Acute symptomatic 23 (38.33%) 16 (27.11%) 39
Remote symptomatic 6 (10.0%) 14 (23.72%) 20
Congenital brain defects 10 (16.66%) 1 (1.69%) 11
Unknown 4 (6.66%) 18 (30.50%) 22
Brain  imaging  (CT  scan,  MRI)  and  electroencephalo-
graphy  (EEG)  were  not  performed  in  about  40%  of  patients
(51.3% for EEG, 38.7% for CT scan and 65.5% for MRI). The
prevalence  of  normal  results  reported  in  patients  undergone
imaging tests, including EEG, CT scan and MRI, was 34.5%,
43.7% and 18.5%, respectively.  A substantial  difference was
observed  in  brain  imaging  and  EEG  results  of  patients  with
normal  and  delayed  development  (Table  3).  Compared  to
patients  with  delayed  development,  patients  with  normal
developmental history had a significantly higher rate of normal
EEG  (84.09%  vs  28.57%;  p<0.001),  CT  scan  (87.27%  vs.
22.22%;  p<0.001)  and  MRI  (72.41%  vs.  8.33%;  p<0.001)
results.
A comparison between brain imaging and EEG in patients
with and without a history of previous SE is shown in Table 4.
Although  the  nonsignificant  difference  was  found  in  brain
imaging results and EEG tests between the two groups, patients
without  a  history  of  previous  SE  had  a  relatively  higher
prevalence of normal results of EEG (72.91% vs. 60.0%), CT
scan (74.6% vs. 50%) and MRI (58.06% vs. 40.0%) compared
to those with a history of SE.
The  morbidity  and  mortality  rates  in  all  patients  were
18.9%  (20  cases)  and  10.9%  (13  cases),  respectively.  There
was  no  substantial  difference  in  morbidity  (p=0.66)  and
mortality  (p=0.35)  rates  between male  (20.33% and 33.89%,
respectively)  and  female  groups  (17.02%  and  34.04%,
respectively).  Correlation  between  mortality  and  morbidity
rates  with  basic  demographic  and  clinical  characteristics  of
patients is shown in Table 5.  While the mean age of patients
with  morbidity  was  notably  higher  than  those  without
morbidity  (59.27  ±  43.47  months  vs.  41.32  ±  36.91  months;
p=0.028), the mortality rate was significantly higher in patients
with  lower  mean  age  compared  to  those  with  a  higher  mean
age  (Table  5).  The  morbidity  and  mortality  rates  in  patients
with delayed development (45.16% and 18.42%, respectively)
were  considerably  higher  than  in  patients  with  normal
development (8% and 7.4%, respectively). The morbidity rate
in patients with previous seizures was meaningfully higher than
those without previous seizures (26.41% vs. 11.32%; p=0.047).
Furthermore,  the morbidity rate in patients with previous SE
was  far  greater  than  those  without  previous  SE  (36.36%  vs.
14.28%; p=0.018). The length of hospital stay in patients with
mortality  was  considerably  longer  than  patients  without
mortality (12.30 ± 16.1 days vs.  7.29 ± 6.24 days;  p=0.033).
The  mortality  rate  in  patients  with  normal  LP  results  was
notably lower than those with abnormal LP results (2.9% vs.
50%).
Correlation  between  mortality  and  morbidity  rates  with
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brain imaging and EEG results indicates that the morbidity rate
in  patients  with  abnormal  EEG (37.5% vs.  7.14%; p=0.022),
CT scan (50% vs. 3.92%; p<0.001) and MRI (88.23% vs. 0%;
p<0.001)  findings  was  meaningfully  greater  than  those  in
patients with normal results. Although the mortality rate was
relatively  higher  in  patients  with  abnormal  EEG  (5.88%  vs.
0%),  CT  (14.28%  vs.  7.69%)  and  MRI  (10.52%  vs.  4.54%),
these differences were not statistically significant (Table 6).






Normal 37 (84.09%) 4 (28.57%) 41
<0.001
Abnormal 7 (15.9%) 10 (71.42%) 17
CT scan
Normal 48 (87.27%) 4 (22.22%) 52
<0.001
Abnormal 7 (12.72%) 14 (77.77%) 21
MRI
Normal 21 (72.41%) 1 (8.33%) 22
<0.001
Abnormal 8 (27.58%) 11 (91.66%) 19
Table 4. Comparison of brain imaging and EEG in patients with and without a history of the previous status.
Imaging type




Normal 6 (60.0%) 35 (72.91%) 41
0.55
Abnormal 4 (40.0%) 13 (27.08%) 15
CT scan
Normal 5 (50%) 47 (74.6%) 52
0.11
Abnormal 5 (50%) 16 (25.39%) 21
MRI
Normal 4 (40.0%) 18 (58.06%) 22
0.33
Abnormal 6 (60.0%) 13 (41.93%) 18






Yes No Yes No
Age (Month) 59.27 ± 43.47 41.32 ± 36.91 0.028 23.15 ± 33.86 47.41 ± 39.98 0.038
Developmental history
     Normal (%) 6 (8.0%) 69 (92.0%)
<0.001
6 (7.4%) 75 (92.59%)
0.073
     Delayed (%) 14 (45.16%) 17 (54.83%) 7 (18.42%) 31 (81.57%)
Previous seizure
     Yes (%) 14 (26.41%) 39 (73.58%)
0.047
7 (11.66%) 53 (88.33%)
0.79
     No (%) 6 (11.32%) 47 (88.67%) 6 (10.16%) 53 (89.83%)
Seizure type
     Focal (%) 6 (25.0%) 18 (75.0%)
0.38
2 (7.69%) 24 (92.3%)
0.55
     Generalized (%) 14 (17.07%) 68 (82.92%) 11 (11.82%) 82 (88.17%)
Seizure lasting (minute) 51.45 ± 28.69 39.16 ± 40.76 0.2 50 ± 27.71 42.06 ± 38.80 0.49
Seizure lasting
     <60 minutes 19 (20.22%) 71 (79.77%)
0.88
11 (11%) 89 (89%)
0.92
     >60 minutes 1 (22.22%) 7 (77.77%) 2 (10%) 9 (90%)
Previous status
     Yes (%) 8 (36.36%) 14 (63.63%)
0.018
2 (8.33%) 22 (91.66%)
0.64
     No (%) 12 (14.28%) 72 (85.71%) 11 (11.57%) 84 (88.42%)
Status with fever
     Yes (%) 10 (16.39%) 51 (83.60%)
0.44
9 (12.85%) 61 (87.14%)
0.41
     No (%) 10 (22.22%) 35 (77.77%) 4 (8.16%) 45 (91.83%)
Family history of FC




     No (%) 18 (19.56%) 74 (80.43%) 13 (12.38%) 92 (87.61%)






Family history of epilepsy
     Yes (%) 7 (29.16%) 17 (70.83%)
0.14
1 (4.0%) 24 (96.0%)
0.21
     No (%) 13 (15.85%) 69 (84.14%) 12 (12.76%) 82 (87.23%)
Hospital stay (day) 7.57 ± 7.45 7.25 ± 5.93 0.9 12.30 ± 16.1 7.29 ± 6.24 0.033
Etiology




     Acute symptomatic 6 (18.18%) 27 (81.81%) 6 (15.38%) 33 (84.61%)
     Remote symptomatic 3 (16.16%) 15 (83.33%) 2 (10%) 18 (90%)
     Congenital brain defects 3 (42.85%) 4 (57.14%) 4 (36.36%) 7 (63.63%)
     Unknown 7 (33.33%) 14 (66.66%) 1 (4.54%) 21 (95.45%)
LP
     Normal 9 (13.43%) 58 (86.56%)
0.69
2 (2.98%) 67 (97.1%)
0.001
     Abnormal 0 (0%) 4 (100%) 1 (50%) 1 (50%)






Yes No Yes No
EEG




     Abnormal (%) 6 (37.5%) 10 (62.5%) 1 (5.88%) 16 (94.11%)
CT scan
     Normal (%) 2 (3.92%) 49 (96.07%)
<0.001
4 (7.69%) 48 (92.3%)
0.38
     Abnormal (%) 11 (50.0%) 11 (50.0%) 3 (14.28%) 18 (85.71%)
MRI
     Normal (%) 0 24 (100%)
<0.001
1 (4.54%) 21 (95.45%)
0.46
     Abnormal (%) 15 (88.23%) 2 (11.76%) 2 (10.52%) 17 (89.74%)
5. DISCUSSION
In this research, we considered the etiology and associated
risk factors of morbidity and mortality in children with status
epilepticus.  We  did  not  find  a  significant  difference  in  S.E
prevalence between male and female groups. The prevalence of
S.E  in  male  and  female  children  was  57.1%  and  42.9%,
respectively. Overall, acute symptomatic (32.8%), febrile status
epilepticus  (22.7%)  and  remote  symptomatic  (16.8%)
etiologies  were  the  most  common  underlying  causes  of  S.E.
While in children less than 3 years old, the acute symptomatic
etiology and febrile status epilepticus etiology were estimated
as the most common causes of S.E. The etiology of S.E in most
patients  older  than  3  years  old  was  unknown.  Acute
symptomatic etiology of SE was the second common cause of
disease in cases older than 3 years old. Our study revealed the
importance of  etiology in predicting mortality  and morbidity
rates following SE, with the highest risk of morbidity (42.85%)
and  mortality  (36.36%)  in  patients  with  congenital  brain
defects  compared  to  the  lowest  morbidity  (3.84%)  and
mortality  (0%)  in  patients  with  febrile  status  epilepticus
etiology.  Cherian  et  al.  [14]  reported  that  infection  (35.7%),
change in antiepileptic drugs (20%), idiopathic (9%), metabolic
disorders (8%), brain infection (6%) and trauma (3.5%) were
the most prevalent causes of S.E in children. Kang et al. [15]
reported that the most common cause of S.E in children was
unknown (40.7%),  which was followed by febrile  conditions
(35.4%),  seizure  (29.1%),  brain  infection  (5.3%),  metabolic
disorders (4.2%), anoxia (3.2%), and trauma (0.5%). Riviello et
al.  [16]  demonstrated  that  remote  symptomatic  (27%),  fever
(17%), cryptogenic (14%), brain abscess (11%), and metabolic
disorders (5%) were the leading causes of SE.
Our  findings  revealed  that  the  morbidity  and  mortality
rates  in  these  patients  were  18.9%  and  10.9%,  respectively.
Similarly, Logroscino et al. [17] reported that the mortality rate
of  children  with  S.E  was  10%,  while  these  results  were
consistent  with  the  findings  of  our  study.  Previous  studies
reported the mortality rate of children with SE from 3.45% to
31.75%  [18  -  19].  Therefore,  it  is  necessary  to  consider  the
etiology  and  role  of  different  factors  in  the  evaluation  of
prognosis,  mortality  and  morbidity  in  these  patients.  Recent
researches have revealed the leading role of various factors in
prognosis,  morbidity  and  mortality  in  children  with  S.E.
Hocker  et  al.,  6  reported  that  long-lasting  mechanical
ventilation was considered an important risk factor in the rate
of mortality among children with SE. In another survey, Ristić
et  al.  [20]  concluded  that  there  was  a  notable  and  positive
correlation between the length of status and mortality rate in
these  cases.  Claassen  et  al.  [21]  found  that  female  gender,
hypoxic-ischemic brain injury and a higher rate of comorbidity
were  important  risk  factors  in  the  prevalence  of  mortality  in
patients  with  SE.  Logroscino  et  al.  [17]  reported  that
generalized myoclonic seizures, refractory seizures, and acute
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symptomatic  were  the  most  important  risk  factors  leading to
increased  mortality  in  children  with  SE.  In  our  study,  acute
symptomatic,  febrile  status  epilepticus  and  remote
symptomatic etiologies were the most common etiologies for
SE; however, the morbidity and mortality rates in patients with
congenital brain defects were higher compared to other types.
In this study, we also found that age, previous history SE,
length  of  hospital  stay,  LP  result,  and  developmental  status
were the most important factors in the evaluation of prognosis
in  mortality  and  morbidity  among  these  patients.  Although
only  two  patients  had  abnormal  LP  results,  further
investigation  is  required  in  assessing  this  etiology.  Our  data
demonstrated  that  the  morbidity  rate  of  older  patients  was
remarkably higher than younger children, while the mortality
rate  in  younger  cases  was  significantly  higher  than  older
children. In a previous study, Koubeissi et al. [18] reported that
there was a meaningful and positive correlation between age
and mortality rate in patients with SE. These data indicate the
importance  of  age  as  a  possible  risk  factor  in  morbidity  and
mortality rates of patients with SE. Developmental status was
another  important  factor  for  the  prognosis  of  morbidity  and
mortality in children with S.E. In our study, 32.2% of patients
had  abnormal  development.  Patients  with  abnormal
development not only had substantially higher morbidity and
mortality rate compared to those with normal development, but
also  they  had  more  prevalent  abnormal  EEG,  CT  and  MRI
results.  Therefore,  it  appears  that  abnormal  development  of
children may be a risk factor for SE incidence, increased risk of
brain damage and subsequently higher morbidity and mortality
rate in these patients.
Some studies  demonstrated  that  40-60% of  patients  with
SE had  no  history  of  previous  seizures  [17,  18].  Kang  et  al.
[15] revealed that 71% of patients under 15 years old had no
history  of  previous  seizures.  In  contrast,  Scholtes  et  al.  [3]
reported that 68% of children with SE had a history of previous
seizures.  In  another  study,  DeLorenzo  et  al.  [22]  found  that
58% of children with SE had no history of seizure. Similar to a
study by DeLorenzo, about 50% of our patients had no history
of  previous  seizures.  Nevertheless,  we  found  a  significant
relationship between morbidity and history of previous SE and
seizure  in  these  patients.  The  prevalence  of  morbidity  in
children with previous SE and seizure was much higher than
those  without  a  previous  history.  These  data  indicate  that
although a history of previous seizures might not be correlated
to the incidence of SE in children, it  can increase the risk of
morbidity and mortality rate in these patients, which needs to
be considered.
Our data also revealed a considerable correlation between
morbidity and mortality with the length of hospital stay. The
length of hospital stay in patients with mortality and morbidity
was  remarkably  higher  than  those  without  morbidity  and
mortality.  Similarly,  several  studies  reported  a  significant
relationship between the length of hospital stay with morbidity
and mortality rate in these patients [23, 24]. Our study revealed
that the brain imaging results were valuable in the evaluation of
prognosis,  morbidity and mortality in these patients.  Patients
with  abnormal  EEG,  CT  and  MRI  findings  had  higher
morbidity  and  mortality  rate  compared  to  those  with  normal
imaging results. Therefore, our data indicate the importance of
age, previous SE, LP results, brain imaging and EEG findings
as  possible  risk  factors  for  morbidity  and  mortality  among
patients with S.E.
CONCLUSION
The results of this study showed that the highest prevalent
etiologies in all patients were correlated to acute symptomatic,
febrile  status  epilepticus  and  remote  symptomatic  etiology.
Various  risk  factors  such  as  age,  abnormal  development,
history  of  previous  SE,  length  of  hospital  stay,  abnormal  LP
results,  abnormal  brain  imaging  and  EEG  results  were
associated with increased morbidity and mortality in children
with  SE.  Therefore,  evaluation  of  these  risk  factors  can  be
helpful in the management, prognosis, evaluation of mortality
and morbidity in children with SE seizures.
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